top of page

Johan Hyllner, Prof.

Board member

Professor Johan Hyllner is Head of Cell Therapy BioPharmaceuticals R&D at AstraZeneca , where he is responsible for the discovery and development of cell therapy based projects from discovery to the clinic.

Johan is a world leading expert in cell therapy and enabling technologies. Prior to joining AstraZeneca in January 2019, Johan was a C-level executive in five start-up companies in the cell therapy area and built these into successful international businesses during the last twenty years. Most recently he held the position as CSO of the Cell and Gene Therapy Catapult Ltd in London, a successful high-profile innovation centre established by the UK government. In addition, Johan has as CSO been part of building Cellectis, Cellartis, SQC Lab and Vitrolife into thriving entities.

Johan is also Professor in Engineering Biology at the Department of Physics, Chemistry and Biology at Linköping University in Sweden and has published more than 60 peer reviewed, full-length articles and a dozen books/chapters.

Johan Hyllner, Prof.
bottom of page